ReviewCureus2026
Colonic Stenting as a Bridge to Surgery Versus Emergency Resection in Left-Sided Malignant Large Bowel Obstruction: A Systematic Review.
Review in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Acute left-sided malignant large bowel obstruction represents a high-risk surgical emergency, frequently associated with significant morbidity, the need for stoma formation, and increased perioperative complications. The use of self-expanding metallic stents (SEMS) as a bridge to surgery has gained prominence as it allows decompression of the obstructed bowel, patient stabilisation, and conversion to a planned elective procedure. This systematic review included seven studies (four randomised controlled trials and three observational cohorts; total n = 819) comparing SEMS as a bridge to surgery with emergency resection. Across the evidence included, SEMS was consistently associated with lower rates of stoma formation and improved facilitation of elective surgery, while short-term morbidity and mortality remained comparable between the two approaches. Stent-related complications, including perforation, were relatively uncommon and largely dependent on operator expertise. Long-term oncological outcomes, including overall survival and disease-free survival, were similar between SEMS and emergency surgery groups, suggesting that the use of SEMS does not adversely affect cancer-related outcomes. Functional benefits, such as effective bowel decompression and improved perioperative optimisation, were more evident in the SEMS group, particularly among elderly patients and those with significant comorbidities. Despite variability in study design and outcome reporting, the overall body of evidence supports SEMS as a safe and effective bridge-to-surgery strategy. It offers meaningful short-term clinical advantages without compromising long-term oncological safety in appropriately selected patients with left-sided malignant large bowel obstruction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.